Account
ArtE wins marketing mandate for Hero Lectro
Mumbai: ArtE Mediatech, India’s leading Creative, Media, and MarTech agency, is delighted to announce its newest collaboration with Hero Lectro. In this exciting partnership, the agency will take charge of the overall planning, strategising, and managing of brand and social media marketing, and performance marketing for Hero Lectro. The mandate has been awarded to Art-E after a multi-agency pitch and will be managed by the agency’s Delhi branch.
Additionally, as a part of the mandate; the agency will also prioritise bolstering brand awareness, enhancing brand recall value, and fostering consideration among consumers. Besides this, ArtE will also assist Hero Lectro in reclaiming the audience’s mind and market share within the e-cycles category.
Delighted with the announcement, Art-E CEO & partner Amit Dhawan said, “We are ecstatic to embark on this new alliance with one of the industry stalwarts. Hero Lectro has been making marks in the industry and redefining mobility in India with unique riding modes. By working together, we are excited to bring our creative ideas and expertise to the forefront and set new boundaries in this industry. I am confident that this partnership will result in great outreach for the brand, and I can’t wait to see how this unfolds.”
Commenting on this partnership, Firefox Bikes Pvt. Ltd. CEO Sriram Sunderson said “We are thrilled to onboard the creative nerds of ArtE Mediatech. Their expertise and capabilities in setting revolutionary marketing trends in the industry are seamlessly aligned with our vision to make Hero Lectro e cycle the most preferred e cycles in India . We look forward to a healthy collaboration and setting new benchmarks in the industry”
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”








